QIAGEN N.V. at Robert W Baird Global Healthcare Conference Transcript
All right. Good afternoon, everyone. I'm Robbie Bamberger, Senior Research Analyst covering Life Sciences and Diagnostics here at Baird. We're pleased to welcome QIAGEN this afternoon.
Especially pleased to welcome John Pratt, who became QIAGEN CEO on September 1. So we're catching him right at the two week mark. We also have Roland Sackers, QIAGEN CFO, and Dominica from IR with us as well. Thank you guys for all making the trip.
Questions & Answers
John, just before we get into the business, I wanted to start with you. You stepped into the CEO seat September 1, so we're catching you two weeks in. What was it about QIAGEN that made you want this job? And in your conversation with the supervisory board, what were they telling you they wanted most for the next CEO of QIAGEN ?
Yeah, thank you again. Good
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
